pharmaceutical-investing Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology
pharmaceutical-investing Nymox Reports 5-Year Results From Prospective Randomized Controlled Prostate Cancer Study of Fexapotide Triflutate
Rio Silver Launches Metallurgical Program to De-Risk Processing and Optimize Silver Recoveries at Maria Norte